Bionime Corp - Asset Resilience Ratio
Bionime Corp (4737) has an Asset Resilience Ratio of 1.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Bionime Corp for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Bionime Corp's Asset Resilience Ratio has changed over time. See what is Bionime Corp's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Bionime Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4737 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$59.34 Million | 1.06% |
| Total Liquid Assets | NT$59.34 Million | 1.06% |
Asset Resilience Insights
- Limited Liquidity: Bionime Corp maintains only 1.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bionime Corp Industry Peers by Asset Resilience Ratio
Compare Bionime Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Bionime Corp (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Bionime Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.06% | NT$61.36 Million ≈ $1.93 Million |
NT$5.78 Billion ≈ $182.14 Million |
-0.02pp |
| 2023-12-31 | 1.08% | NT$57.39 Million ≈ $1.81 Million |
NT$5.30 Billion ≈ $167.00 Million |
-0.19pp |
| 2022-12-31 | 1.27% | NT$63.39 Million ≈ $2.00 Million |
NT$4.98 Billion ≈ $156.99 Million |
-0.04pp |
| 2021-12-31 | 1.31% | NT$59.83 Million ≈ $1.88 Million |
NT$4.56 Billion ≈ $143.79 Million |
+0.06pp |
| 2020-12-31 | 1.25% | NT$56.05 Million ≈ $1.77 Million |
NT$4.49 Billion ≈ $141.30 Million |
+0.74pp |
| 2019-12-31 | 0.51% | NT$22.43 Million ≈ $706.64K |
NT$4.40 Billion ≈ $138.76 Million |
-0.33pp |
| 2018-12-31 | 0.84% | NT$38.59 Million ≈ $1.22 Million |
NT$4.59 Billion ≈ $144.59 Million |
-6.30pp |
| 2017-12-31 | 7.14% | NT$312.28 Million ≈ $9.84 Million |
NT$4.37 Billion ≈ $137.83 Million |
-1.47pp |
| 2016-12-31 | 8.61% | NT$400.00 Million ≈ $12.60 Million |
NT$4.65 Billion ≈ $146.39 Million |
+8.17pp |
| 2015-12-31 | 0.44% | NT$19.96 Million ≈ $628.79K |
NT$4.57 Billion ≈ $143.89 Million |
+0.32pp |
| 2012-12-31 | 0.11% | NT$4.10 Million ≈ $129.30K |
NT$3.63 Billion ≈ $114.43 Million |
-0.50pp |
| 2011-12-31 | 0.61% | NT$17.35 Million ≈ $546.56K |
NT$2.85 Billion ≈ $89.82 Million |
-2.12pp |
| 2010-12-31 | 2.73% | NT$35.12 Million ≈ $1.11 Million |
NT$1.29 Billion ≈ $40.55 Million |
-1.06pp |
| 2009-12-31 | 3.79% | NT$33.79 Million ≈ $1.06 Million |
NT$892.09 Million ≈ $28.11 Million |
-- |
About Bionime Corp
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST… Read more